Ultrasound Study Shows No Link Between COVID-19 Vaccines and Birth Defects
Preliminary ultrasound findings from a study of over 3,000 women in early pregnancy found no association between fetal anomalies and initial COVID-19 vaccination.
For women in early pregnancy, emerging research suggests there is no link between initial dosing of COVID-19 vaccines and fetal structural anomalies.
The cohort study was comprised of 2,622 pregnant women who received at least one dose of a COVID-19 vaccine and 534 unvaccinated pregnant women. Second trimester ultrasound exams revealed fetal structural anomalies in 27 unvaccinated women (5.1 percent) in comparison to 109 women who had at least one vaccine dose (4.2 percent), according to preliminary study findings, published in a research letter in JAMA Pediatrics.
“Our findings suggest that COVID-19 vaccination during early pregnancy is not associated with an increased risk of fetal structural anomalies identified with ultrasonography,” wrote Emily S. Miller, MD, MPH, an assistant professor of obstetrics and gynecology and psychiatry and behavioral sciences with Northwestern University’s Feinberg School of Medicine, and colleagues.
The researchers looked at COVID-19 vaccine administration within and outside of a teratogenic window, which ranged between 30 days prior to conception to 14 weeks of gestation. The study authors noted that 1,149 women received a vaccine dose within the teratogenic window and 1,473 women had the vaccine dose outside of the teratogenic window. Comparing these groups with women who were either unvaccinated or vaccinated outside of the teratogenic window, Dr. Miller and colleagues found similar rates of fetal structural anomalies across all study participants within the teratogenic window and at two to 10 weeks of gestation, according to the study.
Dr. Miller and colleagues said these preliminary findings could be beneficial for clinicians who may be fielding questions about the safety of getting COVID-19 vaccines during early pregnancy.
In regard to study limitations, the study authors noted the data were derived from a single center in a retrospective design. Dr. Miller and colleagues also emphasized the surrogate outcome nature of ultrasonography measures with many of the study participants having ongoing pregnancies.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
